BACKGROUND: Effective programs for promoting physical activity are needed for those with cognitive impairment. OBJECTIVE: To test the feasibility of mobile Health (mHealth) technology-supported physical activity prescription from a tertiary care memory clinic. METHODS: This feasibility study was designed as a 16-week randomized, crossover trial of a physical activity prescription: 8 weeks of intervention, 8 weeks of baseline or maintenance phase data collection. We recruited 2 cohorts: 21 individuals with Alzheimer-related cognitive impairment (mean age 72.3 (5.2), 9 females), and 9 individuals with normal cognition (mean age 69.6 (5.8), 8 females). We gave each cohort an mHealth accelerometer-based physical activity prescription to double number of steps taken. Our primary outcomes were feasibility and safety. Our secondary outcomes were change in weekly steps taken, Dementia Quality of Life Scale, Self-efficacy Scale, 6-minute Walk, and mini-Physical Performance Test. RESULTS: Set-up and use of the device was not a barrier to participation. However, only 62% of participants with cognitive impairment completed the intervention. The cohort with cognitive impairment did not change their weekly step count above Week 1. All participants in the cohort with normal cognition were able to set up and use their device and increased their weekly step count above Week 1. There were no differences between Week 1 and Week 8 for any secondary measures in either cohort. CONCLUSIONS: Setup and daily use of mHealth technology appears to be feasible for a person with cognitive impairment with the help of a partner, but increasing daily step counts over 8 weeks was not achieved. Future work needs to assess alternative activity prescription goals or additional support for patients and their partners.
RCT Entities:
BACKGROUND: Effective programs for promoting physical activity are needed for those with cognitive impairment. OBJECTIVE: To test the feasibility of mobile Health (mHealth) technology-supported physical activity prescription from a tertiary care memory clinic. METHODS: This feasibility study was designed as a 16-week randomized, crossover trial of a physical activity prescription: 8 weeks of intervention, 8 weeks of baseline or maintenance phase data collection. We recruited 2 cohorts: 21 individuals with Alzheimer-related cognitive impairment (mean age 72.3 (5.2), 9 females), and 9 individuals with normal cognition (mean age 69.6 (5.8), 8 females). We gave each cohort an mHealth accelerometer-based physical activity prescription to double number of steps taken. Our primary outcomes were feasibility and safety. Our secondary outcomes were change in weekly steps taken, Dementia Quality of Life Scale, Self-efficacy Scale, 6-minute Walk, and mini-Physical Performance Test. RESULTS: Set-up and use of the device was not a barrier to participation. However, only 62% of participants with cognitive impairment completed the intervention. The cohort with cognitive impairment did not change their weekly step count above Week 1. All participants in the cohort with normal cognition were able to set up and use their device and increased their weekly step count above Week 1. There were no differences between Week 1 and Week 8 for any secondary measures in either cohort. CONCLUSIONS: Setup and daily use of mHealth technology appears to be feasible for a person with cognitive impairment with the help of a partner, but increasing daily step counts over 8 weeks was not achieved. Future work needs to assess alternative activity prescription goals or additional support for patients and their partners.
Entities:
Keywords:
Alzheimer’s disease; clinic activities; exercise; mobile health
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Tari D Topolski; James LoGerfo; Donald L Patrick; Barbara Williams; Julie Walwick; Marsha B Patrick Journal: Prev Chronic Dis Date: 2006-09-15 Impact factor: 2.830
Authors: Lauren T Ptomey; Eric D Vidoni; Esteban Montenegro-Montenegro; Michael A Thompson; Joseph R Sherman; Anna M Gorczyca; Jerry L Greene; Richard A Washburn; Joseph E Donnelly Journal: J Aging Phys Act Date: 2019-09-01 Impact factor: 1.961
Authors: Oleg Zaslavsky; Hilaire J Thompson; Susan M McCurry; Carol A Landis; Spyros Kitsiou; Teresa M Ward; Margaret M Heitkemper; George Demiris Journal: Res Gerontol Nurs Date: 2019-03-25 Impact factor: 1.571
Authors: Emily W Paolillo; Shannon Y Lee; Anna VandeBunte; Nina Djukic; Corrina Fonseca; Joel H Kramer; Kaitlin B Casaletto Journal: Front Digit Health Date: 2022-06-10
Authors: Veronika van der Wardt; Jennie Hancox; Dawid Gondek; Pip Logan; Roshan das Nair; Kristian Pollock; Rowan Harwood Journal: Prev Med Rep Date: 2017-05-18
Authors: José I Recio-Rodríguez; Cristina Lugones-Sanchez; Cristina Agudo-Conde; Jesús González-Sánchez; Olaya Tamayo-Morales; Susana Gonzalez-Sanchez; Carmen Fernandez-Alonso; Jose A Maderuelo-Fernandez; Sara Mora-Simon; Manuel A Gómez-Marcos; Emiliano Rodriguez-Sanchez; Luis Garcia-Ortiz Journal: BMC Geriatr Date: 2019-01-23 Impact factor: 3.921
Authors: Daniel R Bateman; Bhavana Srinivas; Thomas W Emmett; Titus K Schleyer; Richard J Holden; Hugh C Hendrie; Christopher M Callahan Journal: J Med Internet Res Date: 2017-08-30 Impact factor: 5.428
Authors: Wouter M A Franssen; Gregor H L M Franssen; Jan Spaas; Francesca Solmi; Bert O Eijnde Journal: Int J Behav Nutr Phys Act Date: 2020-05-11 Impact factor: 6.457